Fennec Pharmaceuticals (FENC) Revenue Growth (3y) (2023)

Fennec Pharmaceuticals (FENC) Revenue Growth (3y) (2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.84 Bn 467.05 Bn 1.35 Bn 50.07%
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn 7.94%
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn 4.47%
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn 79.44%
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 54.05%
10 Fennec Pharmaceuticals 295.20 Mn 258.41 Mn 12.01 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 265.12%